Clinical Trials Browser

Phase EARLY_PHASE1 × Breast Neoplasms × Breast × Clear all

NCT05291507 2026-03-17

BreastMRgFUS

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07459283 2026-03-10

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

BreastHead & NeckSarcoma

Breast Neoplasms, Head and Neck Neoplasms, Sarcoma, Thyroid Neoplasms

NCT06123286 2026-03-03

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Arthralgia

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Phase EARLY_PHASE1 Active not recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05659797 2026-02-27

FES BPET-DBT in Newly Diagnosed Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07319195 2026-02-18

WINIT-BC

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms

NCT04265872 2026-02-12

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT04016818 2026-02-10

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

Phase EARLY_PHASE1 Recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT06435351 2026-01-29

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06828588 2026-01-29

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Phase EARLY_PHASE1 Not yet recruiting

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT03321045 2026-01-26

Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT05921253 2026-01-26

OU-SCC-NCAN

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Lymphoma

NCT06499090 2026-01-22

Mirtazapine for Acute and Chronic Post Mastectomy Pain

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT06220214 2026-01-15

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT05704283 2025-12-26

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT06274034 2025-12-16

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT04712721 2025-10-10

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Breast Neoplasms, Glioblastoma

NCT05754749 2025-09-25

Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT03802604 2025-09-09

PROMETEO

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Phase EARLY_PHASE1 Active not recruiting

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT05859971 2025-07-29

ICG and SLN Mapping

Phase EARLY_PHASE1 Completed

10 enrolled 7 charts

Breast Neoplasms

NCT06411678 2025-06-17

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT03685175 2025-03-30

HPCardiotox

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT06637306 2025-03-26

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06756295 2025-03-12

FAST-CR

Phase EARLY_PHASE1 Not yet recruiting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT04674722 2024-12-09

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT03514121 2024-11-22

FPA150-001

Phase EARLY_PHASE1 Terminated

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT03911453 2024-10-03

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT04481230 2024-10-01

CARSPECT

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Osteoarthritis, Knee

NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

Phase EARLY_PHASE1 Completed

7 enrolled 13 charts

Breast Neoplasms

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02415387 2024-07-24

IMPACT

Phase EARLY_PHASE1 Completed

172 enrolled 14 charts

Breast Neoplasms, Depression

NCT05549024 2024-07-05

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Phase EARLY_PHASE1 Recruiting

BreastCNSGenitourinary

Brain Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT03542695 2024-06-24

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Calcinosis

NCT04925817 2024-06-07

3D Ultrasound Microvessel Imaging for Breast Masses

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Phase EARLY_PHASE1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

NCT06090630 2024-04-17

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT06361264 2024-04-11

Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms